Gamida Cell Ltd (NASDAQ:GMDA)

1.66
Delayed Data
As of Feb 02
 +0.01 / +0.61%
Today’s Change
1.10
Today|||52-Week Range
4.72
+28.68%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$120.8M

Company Description

Gamida Cell Ltd. engages in the development of cell therapies to cure blood cancer and rare serious hematologic diseases. The firm offers Omidubicel, an investigational product with potential as a life-saving alternative for patients in need of a bone marrow transplant, and a line of modified and unmodified nicotinamide-enabled natural killer cells targeted at solid tumor and hematological malignancies. The company was founded by Tony Peled and Menashe Levy in 1998 and is headquartered in Boston, MA.

Contact Information

Gamida Cell Ltd.
116 Huntington Avenue
Boston Massachusetts 02116
P:(713) 400-6400
Investor Relations:

Employees

Shareholders

Other institutional19.13%
Mutual fund holders13.58%
Individual stakeholders1.15%

Top Executives

Abigail L. JenkinsPresident, Chief Executive Officer & Director
Michele I. KorfinChief Operating & Commercial Officer
Shai LankryChief Financial Officer
Ronit SimantovChief Medical & Scientific Officer
Yona GeffenVice President-Research & Development